References
- 1. Kalck KA: Inflammatory bowel disease in horses. Veterinary Clinics of North America: Equine Practice 2009, 25: 303-315.
- 2. Cerquetella M, Spaterna A, Laus F, Tesci B, Rossi G, Antonelli E, Villanacci V, Bassotti G 2010: Inflammatory bowel diseases in the dog: Differences and similarities with humans. World J Gastroenterol 2010, 16: 1050-1056.
- 3. Jergens AE, Simpson KW: Inflammatory bowel disease in veterinary medicine. Front Biosci 2012, 1: 1404-1419.
- 4. Manichanh C, Borruel N, Casellas F, Guarner F: the gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012, 9: 599-608.
- 5. Wang ZK, Yang YS, Chen Y, Yuan J, Sun G, Peng LH: Intestinl microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J Gastroenterol 2014, 20: 14805-14820.
- 6. Cain AM, Karpa KD: Clinical utility of probiotics in inflammatory bowel disease. Alter Ther Health Med 2011, 17: 72-79.
- 7. Dylag K, Hubalewska-Mazgaj M, Surmiak M, Szmyd J, Brzozowski T: Probiotics in the mechanism of protection against gut inflammation and therapy of gastrointestinal disorders. Curr Pharm Design 2014, 20: 1149-1155.
- 8. Sartor RB: Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004, 126: 1620-1633.
- 9. Toumi R, Soufli I, Rafa H, Belkhelfa M, Biad A, Touil-Boukoffa C: Probiotic bacteria lactobacillus and bifidobacterium attenuate inflammation in dextran sulfate-induced experimental colitis in mice. Int J Immunopathol Pharmacol 2014, 27: 615-627.
- 10. Hijová E, Šoltésová A, Salaj R, Kuzma J, Strojny L, Bomba A: Use of the prebiotic inulin in the prevention of adverse signs of acute colitis. Acta Veterinaria-Beograd 2015, 65: 339-347.
- 11. Vasina V, Brocolli M, Ursino MG, Canistro D, Valgimigli L, Soleti A, Paolini M, DePonti F: Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats. World J Gastroenterol 2010, 16: 3642-3650.
- 12. Strojný L, Bomba A, Hijová E, Chmelárová A, Mojžišová G, Bertková I, Koprovičová J, Pomfy M, Strompfová V, Molokáčová M: Effects of probiotic in combination with prebiotics on intestinal lactobacilli and coliforms and activities of bacterial enzymes in 1,2-dimethylhydrazine exposed rats. Czech J Anim Sci 2011, 56: 99-106.
- 13. Juskiewicz J, Zdunczyk Z, Wroblewska M, Oszmianski J, Hernandez T: The responce of rats to feeding with diets containing grapefruit flavonoid extract. Food Res Int 2002, 35: 201-205.
- 14. Foligné B, Dewulf J, Vandekerckove P, Pignède G, Pot B: Probiotic yeasts: Anti-inflammatory potential of various non-pathogenic strains in experimental cilitis in mice. World J Gastroenterol 2010, 16: 2134-2145.
- 15. Verna EC, Lucak S: Use of probiotics in gastrointestinal disorders: what to recommend? Therapeutic Advances in Gastroenterology 2010, 3: 307-319
- 16. Mack DR: Probiotics in inflammatory bowel diseases and associated conditions. Nutrients 2011, 3: 245-264
- 17. Kuno T, Tsukamoto T, Hara A, Tanaka T: Cancer chemoprevention through the induction of apoptosis by natural compounds. JBC 2012, 3: 156-173.
- 18. Martin KR: Targeting apoptosis with dietary bioactive agents. Experimental Biology and Medicine (Maywood) 2006, 231: 117-129.
- 19. Pulli B, Ali M, Forghani R, Schob S, Hsieh KLC, Wojtkiewicz G, Linnoila JJ, Chen JW 2013: Measuring myeloperoxidase activity in biological samples. PLOS One 2013, 8: 1-10.
- 20. Massodi I, Tijjani BM, Wani H, Hassan NS, Khan AB, Hussain S 2011: Biomarkers in the management of ulcerative colitis: a brief review. German Medical Science 2011, 9: 1-7.